Medicaid Drug Rebate Program Newly Reported Drugs February 2026

U.S. Department of Health & Human Services data on newly reported, active covered outpatient drugs in the Medicaid Drug Rebate Program for the period from February 23 to March 1, 2026. The dataset contains drugs reported by participating manufacturers since the last quarterly database update. Row and column counts are unknown.

Use Cases

• Identify newly reported active covered outpatient drugs for formulary management and coverage analysis.
• Track manufacturer reporting activity for compliance monitoring within the Medicaid Drug Rebate Program.
• Analyze the frequency and timing of new drug entries into the MDRP database following a quarterly update.

Strengths

• Data is provided by the authoritative U.S. Department of Health & Human Services.
• Records are temporally specific, covering a defined one-week reporting period from February 23 to March 1, 2026.
• Focuses on a critical, regulated subset of drugs within the Medicaid Drug Rebate Program.

Limitations

• The dataset's size, including row count and specific features (columns), is completely unknown.
• Lacks sample data, making it impossible to assess data structure, completeness, or quality before access.
• Scope is limited to a single, very recent one-week snapshot, providing no historical context or trend data.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by participating drug manufacturers to the Medicaid Drug Rebate Program (MDRP).

Time Range

February 23, 2026 to March 1, 2026

Freshness

Data was last updated on March 4, 2026, indicating high recency for the reported period.

Geography

United States